ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "macrophages"

  • Abstract Number: 0893 • ACR Convergence 2025

    Transcriptomic insights into GCA compared to clinically diverse controls: Inflammation, Aging, Therapeutic Targets and the role of SPP1 in the temporal artery

    Ingrid Lindquist1, Alisha Eskew2, Dongsoek Choi3, David Wilson4, Diva Salomao5, Hillary Stiefel4, Daniel Albert4, Kiana Vakil-Gilani6, Daniela Ghetie7, James Rosenbaum8 and Marcia Friedman9, 1Portland VA Medical Center, Portland, OR, 2OHSU, Portland, OR, 3OHSU, Portland, 4Casey Eye Institute OHSU, Portland, OR, 5Mayo Clinic, Rochester, MN, 6PeaceHealth, Portland, OR, 7OHSU, Lake Oswego, OR, 8Legacy Devers Eye Institute, Portland, OR, 9Immpact Bio, Beaverton, OR

    Background/Purpose: Giant cell arteritis (GCA) is the most common vasculitis in people over 50 years old and is a clinical diagnosis bolstered by non-specific inflammatory…
  • Abstract Number: 1774 • ACR Convergence 2025

    Citrullinated and Malondialdehyde-Acetaldehyde Co-Modified Fibrinogen Activates Macrophages and Induces Pro-Fibrotic shift in Coronary Endothelium Phenotype

    Nozima Aripova1, Wenxian Zhou2, Hannah Johnson1, Michael Duryee1, Kimberley Sinanan1, Carlos Hunter1, Tate Johnson1, Mabruka Alfaidi1, Daniel Anderson3, Kishore Bidasee1, Geoffrey Thiele1 and Ted Mikuls1, 1University of Nebraska Medical Center, Omaha, NE, 2University of Nebraska Medical Center, Bellevue, NE, 30587964, Durham, NC

    Background/Purpose: Rheumatoid arthritis (RA) patients are at increased risk for developing heart failure with preserved ejection fraction (HFpEF), which is characterized by impaired left ventricular…
  • Abstract Number: 0865 • ACR Convergence 2025

    Spatial Transcriptomic Analysis of Calcinosis Cutis in Dermatomyositis Uncovers Disease-Associated Pathways Involving IL-6, Tissue Remodeling, and Osteopontin

    Cassie Parks1, York Wang1, Lisa Christopher-Stine2, Jemima Albayda2, Joel Sunshine3, Shira Ziegler1 and Chris Mecoli1, 1Johns Hopkins University School of Medicine, Baltimore, MD, 2Johns Hopkins University, Baltimore, MD, 3Johns Hopkins University School of Medicine, Baltimore

    Background/Purpose: Calcinosis cutis affects up to 20% of adults with dermatomyositis (DM), causing significant morbidity including recurrent infections, incapacitating pain, and functional impairment. Current management…
  • Abstract Number: 1763 • ACR Convergence 2025

    Spatial Organization and Function of Disease-Associated Macrophages in Lupus Nephritis: Insights from Cross-Species Analyses

    Paul Hoover1, Chirag Raparia2, Rollin Leavitt3, Nir Hacohen4, Arnon Arazi5 and Anne Davidson2, 1Brigham and Women's Hospital, Boston, MA, 2Feinstein Institutes for Medical Research, Manhasset, NY, 3Broad Institute, Boston, MA, 4Broad Institute, Cambridge, MA, 5The Feinstein Institutes for Medical Research, Manhasset

    Background/Purpose: Myeloid cells are linked to kidney injury in lupus nephritis (LN) but lack targeted therapies, underscoring the need to better understand myeloid biology in…
  • Abstract Number: 0812 • ACR Convergence 2025

    Anti-CD206 CAR T Cell Immunotherapy Mitigates Dermal Pathology in Systemic Sclerosis

    Chanhyuk Park1, Helen Jarnagin2, Asmaa Mohamed3, Noelle Kosarek4, Owen Wilkins1, Fred Kolling1, Yina Huang1, Michael Whitfield5 and Patricia Pioli1, 1Geisel School of Medicine at Dartmouth, Lebanon, NH, 2Dartmouth College, Lebanon, NH, 3Geisel School of Medicine at Dartmouth, Charlottesville, VA, 4Dartmouth Geisel School of Medicine, Lebanon, NH, 5Geisel School of Medicine, Lebanon, NH

    Background/Purpose: Systemic sclerosis (SSc) is a progressive, chronic multi-system disorder of unknown etiology that is characterized by immune dysfunction, fibrosis, and loss of dermal white…
  • Abstract Number: 1650 • ACR Convergence 2025

    Malondialdehyde-Acetaldehyde and Citrulline Modified Proteins are Overexpressed in Cardiac Tissues in Rheumatoid Arthritis-Associated Heart Failure and Mediate Endothelial Cell Dysfunction

    Hannah Johnson1, Wenxian Zhou2, Michael Duryee1, Engle Sharp1, Kimberley Sinanan1, Carlos Hunter1, Tate Johnson1, Mabruka Alfaidi1, Daniel Anderson3, Geoffrey Thiele1 and Ted Mikuls1, 1University of Nebraska Medical Center, Omaha, NE, 2University of Nebraska Medical Center, Bellevue, NE, 30587964, Durham, NC

    Background/Purpose: Previous reports show that malondialdehyde-acetaldehyde (MAA) adducts are overexpressed in RA, especially in joint/lung tissues, and that they colocalize with citrulline (CIT). This is…
  • Abstract Number: 0747 • ACR Convergence 2025

    Patterns of Macrophage Polarization Induced by Serum from Patients with Giant Cell Arteritis and Takayasu’s Arteritis

    Irene Carrión-Barberà1, Ryan D. Stultz2, David Cuthbertson3, Nader Khalidi4, Curry Koening5, Carol Langford6, Carol McAlear7, Paul Monach8, Larry Moreland9, Christian Pagnoux10, Philip Seo11, Kenneth Warrington12, Peter Merkel7 and Christian Lood13, 1Department of Rheumatology. Hospital del Mar, Barcelona, Spain, 2University of Washington, Division of Rheumatology, Seattle, WA, 3University of South Florida, Tampa, 4Department of Medicine, McMaster University and St. Joseph’s Healthcare, Hamilton, Canada, 5University of Texas Dell Medical School, Austin, TX, 6Cleveland Clinic, Moreland Hills, OH, 7University of Pennsylvania, Philadelphia, PA, 8VA Boston Healthcare System, Boston, MA, 9University of Colorado, Denver, CO, 10Mount Sinai Hospital, University Health Network, Toronto, and Canadian Vasculitis Research Network (CanVasc), Toronto, ON, Canada, 11Johns Hopkins University, Baltimore, MD, 12Mayo Clinic, ROCHESTER, MN, 13University of Washington, Division of Rheumatology, Seattle

    Background/Purpose: Macrophages play a central role in the pathogenesis of large-vessel vasculitides, including giant cell arteritis (GCA) and Takayasu’s arteritis (TAK). Characterizing patterns of macrophage…
  • Abstract Number: 1174 • ACR Convergence 2025

    High Prevalence of Autoimmunity in Rosai Dorfman Disease: A Multinational Study

    Mitali Sen1, Gordon Ruan2, Samuel Reynolds3, Haadi Ali3, Xi Yang3, Diana Morlote1, Aishwarya Ravindran1, Lauren Shea1, Matthew Koster4, Jithma Abeykoon2, Hind Salama5, Xin-Xin Cao6, Asra Ahmed3, Ronald Go2 and Gaurav Goyal1, 1University of Alabama at Birmingham, Birmingham, AL, 2Mayo Clinic, Rochester, 3University of Michigan, Michigan, 4Mayo Clinic, Rochester, MN, 5National Guard Health Affairs, Riyadh, Saudi Arabia, 6Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China (People's Republic)

    Background/Purpose: Rosai-Dorfman Disease (RDD), formerly known as sinus histiocytosis with massive lymphadenopathy, was initially thought to be inflammatory or autoimmune in nature. The discovery of…
  • Abstract Number: 0080 • ACR Convergence 2025

    The Role of DICAM in Modulating Macrophage Differentiation and Inflammatory Responses via αvβ3 Integrin Signaling in Rheumatoid Arthritis

    Hanna Lee1, Youn-Kwan Jung2, Sang-il Lee3, Yun-Hong Cheon4 and Hyunjin Lim4, 1Division of Rheumatology, Department of Internal Medicine, Gyeongsang National University Hospital, Changwon, Changwon-si, Kyongsang-namdo, Republic of Korea, 2Institute of Medical Science, Gyeongsang National University, Jinju, Jinju, Kyongsang-namdo, Republic of Korea, 3Department of Internal Medicine and Institute of Medical Science, College of Medicine, Gyeongsang National University and Hospital, Jinju, Republic of Korea, 4Division of Rheumatology, Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Jinju, Kyongsang-namdo, Republic of Korea

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by persistent joint inflammation, cartilage destruction, and bone erosion. Among the various immune cells involved…
  • Abstract Number: 1140 • ACR Convergence 2025

    PGG Suppresses MSU Crystal–Triggered Inflammation and Arachidonic Acid Production in PBMCs

    Sadiq Umar1, Poorna Chandra Rao Yalagala2, Sugasini Dhavamani2 and Sriram Ravindran2, 1University of Illinois at Chicago, Chicago, IL, 2University of Illinois, Chicago, IL

    Background/Purpose: Gout is the most prevalent inflammatory arthritis globally, with rising incidence in both developed and developing regions. It is driven by monosodium urate (MSU)…
  • Abstract Number: 0074 • ACR Convergence 2025

    Rheumatoid Factors (RFs) in RA Patient Sera Do Not Bind To Fc-Free Certolizumab Pegol, But Do Bind To Fc-Containing Anti-TNF-α Biological DMARDs, Driving Immune Complex Formation and Cellular Clearance

    Sophie Hopkin1, Kathryn Malpas1, David Kallenberg1, Jacqueline O'Neill1, Geofrey Odede1, Kerry Tyson1, Sue Cross1, Tatiana SOKOLOVA2, Bernard Lauwerys3, Baran Ufuktepe4, Patrick Durez5, Susanna Bidgood1 and David Humphreys1, 1UCB Pharma, Slough, England, United Kingdom, 2Cliniques Universitaires Saint-Luc – Université catholique de Louvain (UCLouvain) – Institut de Recherche Expérimentale et Clinique (IREC), Rheumatology, Brussels, Brussels Hoofdstedelijk Gewest, Belgium, 3Systemic and Inflammatory Rheumatic Diseases Section, Institute of Experimental and Clinical Research (IREC), UCLouvain, Brussels, Belgium, 4UCB Pharma Istanbul, Turkey, istanbul, Turkey, 5Cliniques Universitaires Saint-Luc – Université catholique de Louvain (UCLouvain) – Institut de Recherche Expérimentale et Clinique (IREC), Rheumatologie, Brussels, Brussels Hoofdstedelijk Gewest, Belgium

    Background/Purpose: RFs are polyclonal autoantibodies which bind the Fc domain of IgGs. Patients with RA and high RF levels experience reduced serum drug concentrations and…
  • Abstract Number: 2600 • ACR Convergence 2025

    Deconstructing Lupus Nephritis Kidney Tissue at Single-Cell Resolution

    Nicholas Sugiarto1, Michelle Curtis2, Siddarth Gurajala2, Thomas Eisenhaure3, Qian Xiao4, Joseph Mears5, Arnon Arazi6, Paul Hoover7, Celine Berthier8, Saori Sakaue9, Andrea Fava10, David Hildeman11, E. Steve Woodle12, Brad Rovin13, Jennifer Barnas14, Maria Dall'Era15, Chaim Putterman16, Diane Kamen17, Maureen McMahon18, Jennifer Grossman19, Kenneth Kalunian20, Jeffrey Hodgin21, Fernanda Payan Schober22, Mariko Ishimori23, Michael Weisman23, William Apruzzese24, Joel Guthridge25, Michael Brenner26, Jennifer Anolik27, David Wofsy28, Judith James25, Deepak Rao7, Anne Davidson29, Michelle Petri30, Jill Buyon31, Nir Hacohen32, Betty Diamond33 and Soumya Raychaudhuri7, 1Harvard Medical School, Brookline, MA, 2Harvard Medical School, Boston, 3Broad Institute, Cambridge, MA, 4Harvard Medical School, Boston, MA, 5Michigan University, Ann Arbor, MI, 6Feinstein Institutes for Medical Research, Acton, MA, 7Brigham and Women's Hospital, Boston, MA, 8University of Michigan, Ann Arbor, MI, 9University of Washington, Yokohama, Japan, 10Johns Hopkins University, Baltimore, MD, 11Cincinnati Children's Hospital, Cincinnati, OH, 12UC Health, Cincinnati, 13The Ohio State University, Columbus, OH, 14University of Rochester, Rochester, NY, 15Division of Rheumatology, University of California, San Francisco, CA, 16Albert Einstein College of Medicine, Safed, Israel, 17Medical University of South Carolina, Johns Island, SC, 18UCLA David Geffen School of Medicine, Los Angeles, CA, 19UCLA, Sherman Oaks, CA, 20UC San Diego, La Jolla, CA, 21University of Michigan, Ann Arbor, 22TTUHSC, El Paso, TX, 23Cedars-Sinai Medical Center, Los Angeles, CA, 24Pfizer, Boston, 25Oklahoma Medical Research Foundation, Oklahoma City, OK, 26Brigham and Women's Hospital, Harvard Medical School, Newton, MA, 27University of Rochester Medical Center, Rochester, NY, 28University of California San Francisco, SF, CA, 29Feinstein Institutes for Medical Research, Manhasset, NY, 30Johns Hopkins University School of Medicine, Timonium, MD, 31NYU Grossman School of Medicine, New York, NY, 32Broad Institute of MIT Harvard, Cambridge, MA, 33The Feinstein Institutes for Medical Research, Manhasset, NY

    Background/Purpose: Lupus nephritis (LN) is a heterogeneous disease driven by diverse immune and tissue cell types. We defined the cell states in the tissue and…
  • Abstract Number: 1141 • ACR Convergence 2025

    Modulation of Inflammatory Responses by Dental Pulp Stem Cell Extracellular Vesicles in Monosodium Urate-Stimulated Macrophages

    Sadiq Umar1, Kasey Leung2 and Sriram Ravindran2, 1University of Illinois at Chicago, Chicago, IL, 2University of Illinois, Chicago, IL

    Background/Purpose: Gout is the most prevalent form of inflammatory arthritis, with rising global incidence. It results from the deposition of monosodium urate (MSU) crystals in…
  • Abstract Number: 0069 • ACR Convergence 2025

    Spatial transcriptomics in rheumatoid arthritis (RA) synovium reveals distinct region-specific fibroblast functions

    Camilla R.L. Machado1, Mina Yao1, David Boyle2, Robert J. Benschop3, James T. Parker3, Wei Wang2 and Gary Firestein1, 1University of California, San Diego, San Diego, CA, 2University of California, San Diego, San Diego, 3Eli Lilly, San Diego

    Background/Purpose: RA synovium displays cellular heterogeneity, with gene expression driving disease pathogenesis. Unbiased cell-specific transcriptomes in RA synovium have previously relied primarily on disaggregated tissues…
  • Abstract Number: 2583 • ACR Convergence 2025

    CCL20+ monocytes expanded by HLA-B*27 fuel Th17 generation in Axial Spondyloarthritis

    Jinyi Zhao1, Feng Liu2, Hui Shi3, Liye Chen1 and Paul Bowness4, 1Botnar Research Center, University of Oxford, Oxford, United Kingdom, 2University of Oxford, Oxford, United Kingdom, 3Botnar Research Center, University of Oxford, Oxford, England, United Kingdom, 4NIHR Oxford Biomedical Research Centre, University of Oxford, NDORMS, Oxford, United Kingdom

    Background/Purpose: Axial spondyloarthritis (AxSpA) is a chronic inflammatory arthritis characterized by monocyte activation and Th17 cell expansion. While HLA-B*27 is the strongest genetic risk factor…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 14
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology